Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond
暂无分享,去创建一个
Izabela D. Madura | M. Czyz | M. Zimecki | J. Bojarska | K. Kaczmarek | M. Remko | W. Wolf | M. Breza | A. Gajos-Michniewicz | Jakub Wojciechowski | J. Wojciechowski | I. Madura | M. Czyż
[1] M. Zimecki,et al. Antiviral Activity of a Cyclic Pro-Pro-β3-HoPhe-Phe Tetrapeptide against HSV-1 and HAdV-5 , 2022, Molecules.
[2] T. Tuccinardi,et al. VenomPred: A Machine Learning Based Platform for Molecular Toxicity Predictions , 2022, International journal of molecular sciences.
[3] G. Spengler,et al. 8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules , 2021, International journal of molecular sciences.
[4] K. Parang,et al. Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold , 2021, Biomolecules.
[5] J. Bojarska. Bio-complexes as supermolecules: towards the design of idealized peptide-based ligands , 2021, Acta Crystallographica Section A: Foundations and Advances.
[6] J. Bojarska. The first supramolecular consideration on crystal of DFMO – promising antiviral and anticancer pan-drug , 2021, Acta Crystallographica Section A: Foundations and Advances.
[7] P. Zielenkiewicz,et al. The role of structural biology in pandemic's puzzles: amino acids and short peptides as key players , 2021, Acta Crystallographica Section A: Foundations and Advances.
[8] M. J. Turner,et al. CrystalExplorer: a program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals , 2021, Journal of applied crystallography.
[9] J. Ferlay,et al. Cancer statistics for the year 2020: An overview , 2021, International journal of cancer.
[10] Hong-Jie Zhang,et al. Natural Cyclopeptides as Anticancer Agents in the Last 20 Years , 2021, International journal of molecular sciences.
[11] Wojciech M. Wolf,et al. Life cycle assessment as tool for realization of sustainable development goals - towards sustainable future of the world: mini review , 2021, Acta Innovations.
[12] M. Zimecki,et al. Effects of Modifications on the Immunosuppressive Properties of Cyclolinopeptide A and Its Analogs in Animal Experimental Models , 2021, Molecules.
[13] G. Borchard,et al. Short peptide sequence enhances epithelial permeability through interaction with protein kinase C. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] P. Naik. Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management , 2021, World journal of oncology.
[15] Siyu Chen,et al. Nanocarrier-Based Drug Delivery for Melanoma Therapeutics , 2021, International journal of molecular sciences.
[16] J. Bojarska. Short Peptides: On the Trail of Future Stem Cell-Based Regenerative Therapies , 2021, International Journal of Nutritional Sciences.
[17] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[18] Elham Mousavinezhad Sarasia,et al. A Global Review on Short Peptides: Frontiers and Perspectives , 2021, Molecules.
[19] J. Bojarska,et al. Ultra-Short Cyclo-Peptides as Bio-Inspired Therapeutics: Proline-Based 2,5-Diketopiperazines (DKP) , 2020 .
[20] M. Czyz,et al. BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAFV600E melanoma cells. , 2020, Cancer letters.
[21] M. Zimecki,et al. Anti-Inflammatory Activity of a Cyclic Tetrapeptide in Mouse and Human Experimental Models , 2020, Pharmaceutics.
[22] Izabela D. Madura,et al. A Proline-Based Tectons and Supramolecular Synthons for Drug Design 2.0: A Case Study of ACEI , 2020, Pharmaceuticals.
[23] J. Moss,et al. Bacterial Cyclodipeptides Target Signal Pathways Involved in Malignant Melanoma , 2020, Frontiers in Oncology.
[24] S. Chutipongtanate,et al. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review) , 2020, International journal of oncology.
[25] T. Chua,et al. The Melanoma and Breast Cancer Association: An Overview of their 'Second Primary Cancers' and the Epidemiological, Genetic and Biological correlations. , 2020, Critical reviews in oncology/hematology.
[26] J. Bojarska,et al. Synthesis, experimental and in silico studies of N-fluorenylmethoxycarbonyl-O-tert-butyl-N-methyltyrosine, coupled with CSD data: a survey of interactions in the crystal structures of Fmoc-amino acids. , 2020, Acta crystallographica. Section C, Structural chemistry.
[27] Wojciech M. Wolf,et al. A Supramolecular Approach to Structure-Based Design with A Focus on Synthons Hierarchy in Ornithine-Derived Ligands: Review, Synthesis, Experimental and in Silico Studies , 2020, Molecules.
[28] M. Czyz,et al. Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity , 2020, Cells.
[29] Peter R. Spackman,et al. Bridging crystal engineering and drug discovery by utilizing intermolecular interactions and molecular shapes in crystals. , 2019, Angewandte Chemie.
[30] J. Bojarska,et al. New synthons in supramolecular chemistry of short biologically active peptides , 2019, Acta Crystallographica Section A: Foundations and Advances.
[31] J. Bojarska,et al. Supramolecular synthon polymorphism in modified amino acids. Structural, conformational and energy landscapes of N-benzoyl-2′-hydroxy-3-methylisovaline , 2019, Journal of Molecular Structure.
[32] P. Hegde,et al. Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab , 2019, Clinical Cancer Research.
[33] N. Ditsch,et al. EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells , 2019, OncoTargets and therapy.
[34] M. Czyz,et al. Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program , 2019, Journal of oncology.
[35] Olivier Michielin,et al. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..
[36] M. Czyz,et al. Whole‐exome sequencing reveals novel genetic variants associated with diverse phenotypes of melanoma cells , 2019, Molecular carcinogenesis.
[37] J. Bojarska,et al. The first insight into the supramolecular structures of popular drug repaglinide: Focus on intermolecular interactions in antidiabetic agents , 2019, Journal of Molecular Structure.
[38] S. Patel,et al. Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study. , 2018, Cancer epidemiology.
[39] David S. Goodsell,et al. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy , 2018, Nucleic Acids Res..
[40] J. Bojarska,et al. Supramolecular Chemistry of Modified Amino Acids and Short Peptides , 2018, Advances in Organic Synthesis.
[41] J. Liaw,et al. Applications of cyclic peptide nanotubes (cPNTs) , 2018, Journal of food and drug analysis.
[42] M. A. Abdalla,et al. Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review , 2018, Molecules.
[43] P. Soares,et al. Melanoma treatment in review , 2018, ImmunoTargets and therapy.
[44] G. Mező,et al. On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site , 2018, Beilstein journal of organic chemistry.
[45] J. Bojarska,et al. The experimental and theoretical landscape of a new antiplatelet drug ticagrelor: Insight into supramolecular architecture directed by C-H⋯F, π⋯π and C-H⋯π interactions , 2018 .
[46] Dmitry S Druzhilovskiy,et al. CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds , 2018, PloS one.
[47] C. Ferrone,et al. Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives. , 2017, Anti-Cancer Agents in Medicinal Chemistry.
[48] H. Pan,et al. Antitumour bioactive peptides isolated from marine organisms , 2017, Clinical and experimental pharmacology & physiology.
[49] Peter R. Spackman,et al. CrystalExplorer model energies and energy frameworks: extension to metal coordination compounds, organic salts, solvates and open-shell systems , 2017, IUCrJ.
[50] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[51] M. Czyz,et al. Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells , 2017, Laboratory Investigation.
[52] J. Bojarska,et al. Quantifying intermolecular interactions in solid state indapamide and other popular diuretic drugs: Insights from Hirshfeld surface study , 2016 .
[53] M. Bar‐eli,et al. Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection , 2016, Front. Genet..
[54] Vincent Zoete,et al. A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules , 2016, ChemMedChem.
[55] N. Thamwattana,et al. Modelling water molecules inside cyclic peptide nanotubes , 2016, Applied Nanoscience.
[56] Girish Kumar Gupta,et al. Chemical Drug Design , 2016 .
[57] J. Bojarska,et al. Investigation of intermolecular interactions in finasteride drug crystals in view of X-ray and Hirshfeld surface analysis , 2015 .
[58] R. Kefford,et al. Immune checkpoint inhibitors in melanoma. , 2015, Melanoma management.
[59] Alexander Tropsha,et al. Pred‐hERG: A Novel web‐Accessible Computational Tool for Predicting Cardiac Toxicity , 2015, Molecular informatics.
[60] M. Reaney,et al. Evaluating the cytotoxicity of flaxseed orbitides for potential cancer treatment , 2015, Toxicology reports.
[61] J. Bojarska,et al. Molecular structure and acidity of captopril, zofenopril and their metabolites captopril disulfide and zofenoprilat , 2015 .
[62] M. Czyz,et al. Phenotypic diversity of patient-derived melanoma populations in stem cell medium , 2015, Laboratory Investigation.
[63] A. Mukherjee. Building upon Supramolecular Synthons: Some Aspects of Crystal Engineering , 2015 .
[64] Leming Sun,et al. Tunable synthesis of self-assembled cyclic peptide nanotubes and nanoparticles. , 2015, Soft matter.
[65] J. Bojarska,et al. Captopril and its dimer captopril disulfide: comparative structural and conformational studies. , 2015, Acta crystallographica. Section C, Structural chemistry.
[66] M. Ramamoorthy,et al. In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases , 2015, Bioinformation.
[67] G. Sheldrick. Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.
[68] J. Bojarska,et al. Structural and spectroscopic characterization and Hirshfeld surface analysis of major component of antibiotic mupirocin – pseudomonic acid A , 2014 .
[69] C. Jelsch,et al. The enrichment ratio of atomic contacts in crystals, an indicator derived from the Hirshfeld surface analysis , 2014, IUCrJ.
[70] Tjelvar S. G. Olsson,et al. Evaluation of molecular crystal structures using Full Interaction Maps , 2013 .
[71] J. Bojarska,et al. Three new olanzapine structures: the acetic acid monosolvate, and the propan-2-ol and propan-2-one hemisolvate monohydrates. , 2013, Acta crystallographica. Section C, Crystal structure communications.
[72] Gautam R Desiraju,et al. Crystal engineering: from molecule to crystal. , 2013, Journal of the American Chemical Society.
[73] J. Bojarska,et al. An orthorhombic polymorph of a cyclization product of perindopril. , 2013, Acta crystallographica. Section C, Crystal structure communications.
[74] J. Bojarska,et al. Molecular structure of antihypertensive drug perindopril, its active metabolite perindoprilat and impurity F , 2013 .
[75] J. Bojarska,et al. CRYSTAL STRUCTURE OF A PERINDOPRIL CYCLIZATION PRODUCT, C19H30N2O4 , 2013 .
[76] Niall J. Haslam,et al. Towards the Improved Discovery and Design of Functional Peptides: Common Features of Diverse Classes Permit Generalized Prediction of Bioactivity , 2012, PloS one.
[77] J. Bojarska,et al. Novel pseudopolymorph of the active metabolite of perindopril. , 2012, Acta crystallographica. Section C, Crystal structure communications.
[78] M. Liu,et al. Self‐Assembling Nanotubes Consisting of Rigid Cyclic γ‐Peptides , 2012 .
[79] P. Leeson,et al. Drug discovery: Chemical beauty contest , 2012, Nature.
[80] S. Joo. Cyclic Peptides as Therapeutic Agents and Biochemical Tools , 2012, Biomolecules & therapeutics.
[81] C. Valéry,et al. Peptide nanotubes: molecular organisations, self-assembly mechanisms and applications , 2011 .
[82] J. Bojarska,et al. Crystal and molecular structure of perindopril erbumine salt , 2011 .
[83] J. Rundhaug,et al. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression , 2011, Molecular carcinogenesis.
[84] Z. Wawrzak,et al. The first crystal structure of a gramicidin complex with sodium: high-resolution study of a nonstoichiometric gramicidin D-NaI complex. , 2010, Acta crystallographica. Section D, Biological crystallography.
[85] Gautam R. Desiraju,et al. Long-range synthon Aufbau modules (LSAM) in crystal structures: systematic changes in C6H6−nFn (0 ≤ n ≤ 6) fluorobenzenes , 2010 .
[86] S. Narumiya,et al. Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[87] Richard J. Gildea,et al. OLEX2: a complete structure solution, refinement and analysis program , 2009 .
[88] E. Espinosa,et al. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma. , 2009, European journal of cancer.
[89] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[90] Dylan Jayatilaka,et al. Hirshfeld surface analysis , 2009 .
[91] C. Macrae,et al. Mercury CSD 2.0 – new features for the visualization and investigation of crystal structures , 2008 .
[92] E. Poluzzi,et al. The hERG K+ channel: target and antitarget strategies in drug development. , 2008, Pharmacological research.
[93] Z. Wawrzak,et al. Nonstoichiometric complex of gramicidin D with KI at 0.80 A resolution. , 2007, Acta crystallographica. Section D, Biological crystallography.
[94] E. Baerends,et al. Kohn-Sham Density Functional Theory: Predicting and Understanding Chemistry , 2007 .
[95] P. Kongsaeree,et al. Beta2-amino acids in the design of conformationally homogeneous cyclo-peptide scaffolds. , 2006, The Journal of organic chemistry.
[96] Matthew P Jacobson,et al. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. , 2006, Journal of the American Chemical Society.
[97] Y. Martin,et al. A bioavailability score. , 2005, Journal of medicinal chemistry.
[98] W. Pangborn,et al. Structure of gramicidin D-RbCl complex at atomic resolution from low-temperature synchrotron data: interactions of double-stranded gramicidin channel contents and cations with channel wall. , 2005, Acta crystallographica. Section D, Biological crystallography.
[99] W. Pangborn,et al. Ion channels in crystals of gramicidin D complex with RbCl. Atomic resolution low-temperature synchrotron X-ray data , 2004 .
[100] J. G. Snijders,et al. Accuracy of geometries: influence of basis set, exchange–correlation potential, inclusion of core electrons, and relativistic corrections , 2004 .
[101] Giovanni Scalmani,et al. Energies, structures, and electronic properties of molecules in solution with the C‐PCM solvation model , 2003, J. Comput. Chem..
[102] F. Allen. The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.
[103] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[104] F. Allen,et al. Cambridge Structural Database , 2002 .
[105] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[106] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[107] V. Barone,et al. Quantum Calculation of Molecular Energies and Energy Gradients in Solution by a Conductor Solvent Model , 1998 .
[108] Gautam R. Desiraju,et al. Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .
[109] A. Becke. Density-functional thermochemistry. III. The role of exact exchange , 1993 .
[110] J. Bernstein,et al. Graph-set analysis of hydrogen-bond patterns in organic crystals. , 1990, Acta crystallographica. Section B, Structural science.
[111] H. Kessler,et al. Conformation of Antamanide , 1989 .
[112] A. Becke,et al. Density-functional exchange-energy approximation with correct asymptotic behavior. , 1988, Physical review. A, General physics.
[113] L. Curtiss,et al. Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint , 1988 .
[114] John E. Carpenter,et al. Analysis of the geometry of the hydroxymethyl radical by the “different hybrids for different spins” natural bond orbital procedure , 1988 .
[115] Parr,et al. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.
[116] Frank Weinhold,et al. Natural localized molecular orbitals , 1985 .
[117] F. Weinhold,et al. Natural population analysis , 1985 .
[118] Frank Weinhold,et al. Natural bond orbital analysis of near‐Hartree–Fock water dimer , 1983 .
[119] F. L. Hirshfeld. Bonded-atom fragments for describing molecular charge densities , 1977 .
[120] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .
[121] I. Karle,et al. Conformations of the li-antamanide complex and na-[phe, val]antamanide complex in the crystalline state. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[122] J. Bojarska,et al. Supramolecular Synthons as Related to Cooperativity in Biocomplexes: towards Design and Development of Oligopeptide-Based Modern Drugs and Cosmeceuticals , 2019 .
[123] R. V. Van Dross,et al. Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[124] Nicole J. Yang,et al. Getting across the cell membrane: an overview for small molecules, peptides, and proteins. , 2015, Methods in molecular biology.
[125] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[126] T. Wieland,et al. Conformation of [4-cis-Br-Pro7]-antamanide crystallized from methanol/water , 2004, Naturwissenschaften.
[127] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[128] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[129] Nicholas C. Handy,et al. Exchange functionals and potentials , 1996 .
[130] A. Klamt,et al. COSMO : a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient , 1993 .
[131] R. Parr. Density-functional theory of atoms and molecules , 1989 .